Veterinary Medicine Sulfadiazine Sodium Injection for Animal Use

• Customization: Available
• Varieties: General Disease Prevention Medicine
• Component: Chemical Synthetic Drugs
• Model NO.: Sulfadiazine Sodium Injection
• Type: The First Class
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 22004
• Main Component: Sulfadiazine Sodium
• Description: a Clear, Colorless to Slightly Yellow Liquid
• Indications for Use: Antimicrobials of Sulfonamides
• Administration: Injection
• Withdrawl: 10-18 Days
• GMP: 22018
• Transport Package: Air Way/Sea Way
• Specification: 2ml/vial
• Trademark: SINDER
• Origin: Sichuan, China
• HS Code: 3004209099
• Production Capacity: 1000000L/Year
• Package Size: 45.00cm * 31.00cm * 23.00cm
• Package Gross Weight: 9.300kg

Product Description

Sulfadiazine Sodium Injection
Veterinary OTC drug
(Veterinary Drug name)Sulfadiazine Sodium Injection
(Main Component)Sulfadiazine Sodium
(Description)A clear, colorless to slightly yellow liquid.
(Drug-Drug Interaction)
1. Should not be mixed with tetracycline, kanamycin, lincomycin injection.
2. When the product is used with TMP (Antibacterial synerists) together, it has synergetic effect.
3. It will reduce the effect when the product is used with following drugs, like Procaine, Tetracaine and yeast.
4. It could worsen toxicity of kidney when the product is used with Diuretic, Thiazine or Furosemide.
(Indications for Use)Antimicrobials of Sulfonamides. The product is used for infections caused by sensitive bacteria,which is also used for pig's Toxoplasma infection.
(Administration and Dosage)
Intravenous injection, 0.25-0.5 ml per 1kg weight of livestock for each dosage. 1-2 dosage/day, continuously use for 2 to 3 days.
(Adverse Effect)
1. Sulfanilamide or its metabolin will produce sediment in urine. It will be much easier to get crystal after high dose administration or low dose administration for long term, which will cause crystalluria, hematuresis or kidney tubules blockage.
2. Intravenous injection to horse may cause temporary paralysis.
3. Cute poisoning: more often occurs when intravenous injection was too fast or with excessive dosage.
(Precaution) 
1. This product could produce crystal with acid, so it could not be diluted by 5% of Glucose liquid.
2. It will produce crystalluria when use for long term or high dose administration, the product shall be together used with Sodium Bicarbonate, and large quantity of water should be given to the livestock.
3. Stop using when anaphylaxis or other serious adverse effect happen, and give symptomatic treatment.
(Withdrawl) 
10 days for cow, 18 days for sheep, 10 days for swine.  Withdrawal period for milk is 3 days.
(Specification)2ml:0.4g  
(Package)2ml/vial,10vials/box.
(Storage and Validity)Preserve in well closed containers, protected from light.
Approval No.: Veterinary drug 220041632
Executive Standard: <Chinese Veterinary Pharmacopoeia>, 2015 version, 1^st section.
Producing License No.: (2015) Veterinary drug 22004.
Veterinary GMP Approval No.: (2015) Veterinary drug GMP No.22018.
Address: Zitong Economic zone, Mianyang, Sichuan Province, China.
 

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.